Edited by Dentaltown staff
CERRITOS, Calif.—Millennium Dental has demonstrated that tissues lost to disease can be fully regenerated and return to functional health.
The pathway of tissue regeneration researched and cleared was tissues lost and destroyed as a result of infectious, inflammatory periodontal disease. This suggests there may be other pathways to tissue regeneration in the body that could now be investigated.
“Our preliminary understanding is that we are able to stimulate and activate stem cells, in particular fibroblasts, to form the necessary cellular components that turn into regenerated tissues. This is the first example of functional regeneration as a result of a protocol and device, where regeneration would otherwise not occur,” said Robert H. Gregg II, DDS, co-founder of MDT, inventor of the LANAP protocol, co-developer of the PerioLase MVP-7. “If we can regenerate tissues destroyed by infection and inflammation in a cesspool of saliva and bacteria, the implications for what else could be regenerated elsewhere in the body are worth investigation.”
The PerioLase MVP-7 received regulatory clearance using the LANAP/LAR protocol for: “Periodontal regeneration—true regeneration of the attachment apparatus (new cementum, new periodontal ligament, and new alveolar bone) on a previously diseased root surface when used specifically in the LANAP protocol.” (FDA 510(k)-151763).
The LANAP/LAR procedures with the PerioLase MVP-7 achieve these results with:
- No biologics
- No growth factors
- No exogenous bone grafts
- No foreign membranes
- No scaffolding
- No stitches
MDT has trained 2,000 credentialed LANAP regenerative specialists that include general practitioners and periodontists alike. LANAP regenerative specialists are found in every U.S. state and major metropolis, as well as Puerto Rico, the U.S. Virgin Islands, and Guam.
“This new FDA indication for use changes the meaning of ‘return to periodontal health.’ No longer is return to periodontal health defined by filling holes or cutting away tissue. The FDA clearance reflects what we understood from two human histological studies—the LANAP protocol produces both periodontal tissue regeneration and function to previously diseased tissues," said Dawn M. Gregg, DDS, director of training for the Institute for Advanced Laser Dentistry.